查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439971

经颅磁刺激 (TMS) - 全球市场回顾、竞争格局、市场预测 (2030)

Transcranial Magnetic Stimulator - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球经颅磁刺激 (TMS) 市场规模将于 2023 年达到 11.3461 亿美元，到 2030 年将达到 191705 万美元，预计 2024-2030 年复合年增长率为 9.19%。 经颅磁刺激（TMS）的需求主要是由于阿兹海默症、帕金森氏症等各种神经系统疾病患者数量的不断增加，以及双相情感障碍、强迫症等精神疾病合併症病例的迅速增加等。在意识提高、吸烟者数量增加、对非侵入性治疗的日益偏好以及产品开发技术创新的推动下，这些是 2024-2030 年预测期内经颅磁刺激 (TMS) 增长的关键驱动力。到整体市场的成长。

经颅磁刺激 (TMS) 市场动态

忧郁症、强迫症等精神疾病的持续增加正在推动经颅磁刺激（TMS）市场的成长。 根据世界卫生组织 (WHO) 2022 年发布的数据，2019 年全球约有 9.7 亿人（即八分之一的人）患有精神障碍。 文件进一步指出，焦虑症和忧郁症是2019年全球最常见的精神障碍，影响3.01亿人，其中包括5,800万名儿童和青少年。

根据上述数据，2019年，约有2.8亿人（其中包括2,300万名儿童和青少年）患有忧郁症，占世界人口的3.8%。

上述文件进一步指出，2019年，全球有4000万人患有双相情感障碍，2019年，包括儿童和青少年在内的4000万人患有反社会行为障碍。

多种神经系统疾病的盛行率正在增加，这可能会对经颅磁刺激 (TMS) 市场产生正面影响。 根据世界卫生组织 (2022) 的数据，2019 年全球约有 850 万人受到帕金森氏症 (PD) 的影响，根据同一来源，帕金森氏症与 580 万残疾调整生命年相关。 患有帕金森氏症和阿兹海默症等神经系统疾病的患者可以从 TMS 治疗中受益。

然而，与 TMS 疗法相关的副作用以及其他替代刺激疗法的存在可能会抑制经颅磁刺激 (TMS) 市场的成长。

经颅磁刺激（TMS）市场区隔分析

按经颅磁刺激 (TMS) 市场的类型细分，深部经颅磁刺激 (dTMS) 类别预计将在 2023 年获得可观的收入占有率。 这可能是由于深部经颅磁刺激（dTMS）的好处和应用与神经精神疾病的有效治疗有关。

透过刺激大脑更深更广的区域，深度TMS以非侵入性和创新的方式为许多心理健康状况包括脑震盪、创伤后压力症候群、忧郁、强迫症、焦虑、成瘾等提供有效的治疗。

透过直接激活 H 线圈，dTMS 允许磁脉衝瞄准大脑的特定区域，而无需显着增加磁场强度，从而最大限度地减少治疗的副作用和负面影响。

在尝试各种治疗后症状没有改善的 MDD 患者可能会透过深度 TMS 得到缓解，与抗忧郁药物相比，其风险更小，结果更好。

使用深度 TMS 可以消除与使用抗忧郁药物相关的副作用，例如噁心、体重增加、不孕症、嗜睡、慢性腹泻、口干、皮疹和记忆丧失。

因此，由于上述因素，预计深部经颅磁刺激 (dTMS) 类别将显着成长，从而推动整个经颅磁刺激 (TMS) 市场在预测期内的成长。

预计北美将主导整个经颅磁刺激 (TMS) 市场。

在所有地区中，预计到 2023 年，北美将占据经颅磁刺激 (TMS) 市场的最大占有率。 由于神经系统疾病盛行率不断上升、精神疾病患者数量不断增加、可支配收入高、医疗保健基础设施完善、大公司的存在、产品开发活动不断增加以及其他显着的增长因素，经颅磁刺激（TMS）市场预计见证该地区在 2022-2028 年预测期内的繁荣。

本报告提供了全球经颅磁刺激 (TMS) 市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章经颅磁刺激 (TMS) 市场报告简介

第 2 章经颅磁刺激 (TMS) 市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估

第三章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章经颅磁刺激（TMS）市场主要因素分析

  • 经颅磁刺激 (TMS) 市场驱动因素
  • 经颅磁刺激 (TMS) 市场的限制与挑战
  • 经颅磁刺激 (TMS) 市场机会

第五章波特对经颅磁刺激 (TMS) 市场的五力分析

第六章经颅磁刺激（TMS）市场布局

  • 依类型
    • 深部经颅磁刺激 (dTMS)
    • 重复经颅磁刺激 (rTMS)
    • 其他
  • 依用途
    • 阿兹海默症
    • 强迫症 (OCD)
    • 双极性忧郁症
  • 依年龄段
    • 成人
    • 儿童
  • 地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第 7 章经颅磁刺激 (TMS) 市场公司与产品概况

  • BrainsWay
  • Nexstim
  • Magstim
  • Neuronetics
  • Salience
  • MagVenture, Inc.
  • Axilum Robotics
  • Brainbox Ltd.
  • EB Neuro S.p.A.
  • eNeura Inc.
  • Neurosoft
  • MAG & More GmbH
  • Soterix Medical Inc.
  • Magnus Medical
  • NEUROPREX INC.

第8章KOL浏览量

第 9 章专案方法

第10章DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明与联络我们

Product Code: DIMDCL0652

Transcranial Magnetic Stimulation (TMS) Market By Type (Deep Transcranial Magnetic Stimulator (DTMS), Repetitive Transcranial Magnetic Stimulator (RTMS), And Others), Application (Alzheimer's Disease, Obsessive Compulsive Disorder (OCD), Bipolar Depression, And Others), Age Group (Adults And Children), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of depression and rising prevalence of neurological diseases

The global transcranial magnetic stimulation (TMS) market was valued at USD 1,134.61 million in 2023, growing at a CAGR of 9.19% during the forecast period from 2024 to 2030 to reach USD 1,917.05 million by 2030. The demand for transcranial magnetic stimulation (TMS) is primarily being boosted by the increasing patient population suffering from various neurological diseases such as Alzheimer's Disease and Parkinson's disease among others, as the surge in cases of psychiatric comorbidities such as bipolar disorder, obsessive-compulsive disorder, and others, rising awareness regarding mental health, rise in many smokers, growing preference for non-invasive treatment methods, and innovation in product development among others, thereby contributing to the overall growth of the transcranial magnetic stimulation (TMS) market during the forecast period from 2024-2030.

Transcranial Magnetic Stimulation (TMS) Market Dynamics:

The continuous rise in cases of psychiatric comorbidities such as depression, obsessive-compulsive disorder, and others is driving the growth of the transcranial magnetic stimulation (TMS) market. As per the data published by World Health Organization (WHO) in 2022, worldwide around 970 million people which makes 1 in every 8 people were living with a mental disorder in 2019. The source further stated that anxiety and depressive disorders with anxiety affecting 301 million people including 58 million children and adolescents were the most common mental disorders in 2019 globally.

As per the above-mentioned source worldwide around 280 million people making up 3.8% of the global population including 23 million children and adolescents were suffering from depression in 2019.

The source mentioned above further stated that worldwide 40 million people experienced bipolar disorder in 2019 and 40 million people, including children and adolescents, were living with conduct-dissocial disorder in 2019.

The prevalence of several neurological disorders is on the rise which can have a positive impact on the transcranial magnetic stimulation (TMS) market. According to WHO 2022, worldwide around 8.5 million people had Parkinson's disease (PD) in 2019 and as per the same source, PD lead to 5.8 million disability-adjusted life years. Patients suffering from neurological disorders such as Parkinson's, Alzheimer's disease, and others can get benefit from TMS therapy.

However, side effects associated with TMS therapy and the presence of other alternative stimulation therapies may restrict the growth of the transcranial magnetic stimulation (TMS) market.

Transcranial Magnetic Stimulation (TMS) Market Segment Analysis:

Transcranial Magnetic Stimulation (TMS) Market by Type (Deep Transcranial Magnetic Stimulator (dTMS), Repetitive Transcranial Magnetic Stimulator (rTMS), and Others), Application (Alzheimer's Disease, Obsessive Compulsive Disorder (OCD), Bipolar Depression, and Others), Age Group (Adults and Children), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the transcranial magnetic stimulation (TMS) market, the deep transcranial magnetic stimulator (dTMS) category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with deep transcranial magnetic stimulator (dTMS) effective treatment of neuropsychiatric disorders.

By stimulating the deeper, wider regions of the brain, Deep TMS offers non-invasive, innovative, and effective treatment for numerous mental health conditions including concussions, PTSD, depression, OCD, anxiety, addiction, and more.

The direct activation of H-coils in dTMS enables the magnetic pulses to target specific brain regions without significantly increasing the strength of the magnetic field which helps minimize side effects and negative consequences of the treatment.

Patients with MDD whose symptoms have not improved despite trying various treatments may get relief from deep TMS which offers risk-free and favorable results over antidepressants.

The side effects such as nausea, weight gain, infertility, drowsiness, chronic diarrhea, dry mouth, rash, or memory loss associated with the use of antidepressant drugs are eliminated with the utilization of deep TMS.

Therefore, owing to the above-mentioned factors, the deep transcranial magnetic stimulator (dTMS) category is expected to register significant growth, thereby driving the growth of the overall transcranial magnetic stimulation (TMS) market during the forecast period.

North America is expected to dominate the overall Transcranial Magnetic Stimulation (TMS) Market:

Among all the regions, North America is estimated to account for the largest share of the transcranial magnetic stimulation (TMS) market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of neurological disorders, increasing cases of psychiatric disorders, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for transcranial magnetic stimulation (TMS) is expected to witness prosperity in the region during the forecast period 2022-2028.

According to the National Institute of Mental Health (NIMH) 2022, about 52.9 million people which stands for 21% of the population experienced mental illness in 2020 in the United States. As per the same source 14.2 million people experienced serious mental illness in the United States in 2020.

The above-mentioned source further stated that around 21.0 million adults had at least one major depressive episode in 2020 in the United States.

Another factor contributing to the growth of the TMS market is the continued rise in the number of individuals involved in smoking. For instance, as per the Centers for Disease Control and Prevention 2022, approximately 40 million people smoke cigarettes in the US. As per the same source, every day nearly 1,600 US youth aged 18 years or younger smoke their first cigarette.

Coupled with the factors mentioned above, the increasing interest of product manufacturers in the region also helps in boosting regional product demand. For instance, in August 2020, BrainsWay Ltd., a global leader in the advanced non-invasive treatment of brain disorders, announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Company's deep transcranial magnetic stimulation (Deep TMS) system for its use as an aid in short-term smoking cessation in adults.

Such measures help in gaining the market share for the manufacturers as well as benefit end users in terms of better product pricing from the competition standpoint, thereby driving the North America transcranial magnetic stimulation (TMS) market forward during the forecast period.

Transcranial Magnetic Stimulation (TMS) Market Key Players:

Some of the key market players operating in the transcranial magnetic stimulation (TMS) market include BrainsWay, Nexstim, Magstim, Neuronetics, Salience, MagVenture, Inc., Axilum Robotics, Brainbox Ltd., EB Neuro S.p.A., eNeura Inc., Neurosoft, MAG & More GmbH, Soterix Medical Inc., Magnus Medical, NEUROPREX INC., and others.

Recent Developmental Activities in the Transcranial Magnetic Stimulation (TMS) Market:

In January 2023, Magstim, a global leader in neuroscience research and transcranial magnetic stimulation (TMS) solutions for mental health, announced that it has received US FDA clearance for its Horizon 3.0 (with or without StimGuide+) and E-z Cool Coil to treat adult patients diagnosed with obsessive compulsive disorder (OCD) as well as major depressive disorder (MDD).

In March 2020, Neuronetics, Inc., a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced that the US Food and Drug Administration (FDA) has recently granted Breakthrough Device Designation for the Company's NeuroStar Advanced Therapy System for the treatment of bipolar depression.

Key Takeaways from the Transcranial Magnetic Stimulation (TMS) Market Report Study

Market size analysis for current transcranial magnetic stimulation (TMS) market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the transcranial magnetic stimulation (TMS) market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global transcranial magnetic stimulation (TMS) market.

Various opportunities available for the other competitor in the transcranial magnetic stimulation (TMS) market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current transcranial magnetic stimulation (TMS) market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for transcranial magnetic stimulation (TMS) market growth in the coming future?

Target Audience who can be benefited from this Transcranial Magnetic Stimulation (TMS) Market Report Study

Transcranial Magnetic Stimulation (TMS) products providers

Research organizations and consulting companies

Transcranial Magnetic Stimulation (TMS) -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in transcranial magnetic stimulation (TMS)

Various End-users who want to know more about the transcranial magnetic stimulation (TMS) market and the latest technological developments in the transcranial magnetic stimulation (TMS) market.

Frequently Asked Questions for the Transcranial Magnetic Stimulation (TMS) Market:

1. What is meant by transcranial magnetic stimulation (TMS)?

Transcranial magnetic stimulation (TMS) which involves the application of powerful magnetic fields to particular areas of the brain is safe, non-invasive, and powerful technique indicated for the treatment of various psychiatric and neurological disorders.

2. What is the market for global transcranial magnetic stimulation (TMS)?

The global transcranial magnetic stimulation (TMS) market was valued at USD 1,134.61 million in 2023, growing at a CAGR of 9.19% during the forecast period from 2024 to 2030 to reach USD 1,917.05 million by 2030.

3. What are the drivers for the global transcranial magnetic stimulation (TMS) market?

The demand for transcranial magnetic stimulation (TMS) is primarily being boosted by the increasing patient population suffering from various neurological diseases such as Alzheimer's Disease and Parkinson's disease among others, as the surge in cases of psychiatric comorbidities such as bipolar disorder, obsessive-compulsive disorder, and others, rising awareness regarding mental health, rise in several smokers, and others, thereby contributing to the overall growth of the transcranial magnetic stimulation (TMS) market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Transcranial Magnetic Stimulation (TMS) market?

Some of the key market players operating in the transcranial magnetic stimulation market include BrainsWay, Nexstim, Magstim, Neuronetics, Salience, MagVenture, Inc., Axilum Robotics, Brainbox Ltd., EB Neuro S.p.A., eNeura Inc., Neurosoft, MAG & More GmbH, Soterix Medical Inc., Magnus Medical, NEUROPREX INC., and others.

5. Which region has the highest share in the transcranial magnetic stimulation (TMS) market?

North America is expected to dominate the overall transcranial magnetic stimulation (TMS) market during the forecast period from 2024-2030. Owing to the factors such as the rising prevalence of neurological disorders, increasing cases of psychiatric disorders, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness among others, the North America transcranial magnetic stimulation (TMS) market is expected to grow in coming years.

Table of Contents

1.Transcranial Magnetic Stimulation (TMS) Market Report Introduction

2. Transcranial Magnetic Stimulation (TMS) Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Transcranial Magnetic Stimulation (TMS) Market Key Factors Analysis

  • 4.1. Transcranial Magnetic Stimulation (TMS) Market Drivers
    • 4.1.1. Increasing prevalence of neurological disorders
    • 4.1.2. Surge in cases of psychiatric comorbidities such as depression, obsessive-compulsive disorder, and others
    • 4.1.3. Growing preference for non-invasive treatment options
  • 4.2. Transcranial Magnetic Stimulation (TMS) Market Restraints and Challenges
    • 4.2.1. Side effects associated with TMS therapy
    • 4.2.2. Presence of other alternative stimulation therapies
  • 4.3. Transcranial Magnetic Stimulation (TMS) Market Opportunities
    • 4.3.1. Need to develop well-standardized protocols for TMS
    • 4.3.2. Personalization of TMS therapy

5. Transcranial Magnetic Stimulation (TMS) Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Transcranial Magnetic Stimulation (TMS) Market Layout

  • 6.1. By Type
    • 6.1.1. Deep Transcranial Magnetic Stimulator (dTMS)
    • 6.1.2. Repetitive Transcranial Magnetic Stimulator (rTMS)
    • 6.1.3. Others
  • 6.2. By Application
    • 6.2.1. Alzheimer's disease
    • 6.2.2. Obsessive-compulsive disorder (OCD)
    • 6.2.3. Bipolar Depression
    • 6.2.4. Others
  • 6.3. By Age Group
    • 6.3.1. Adults
    • 6.3.2. Children
  • 6.4. By Geography
    • 6.4.1. North America
      • 6.4.1.1. United States Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
    • 6.4.2. Europe
      • 6.4.2.1. France Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific
      • 6.4.3.1. China Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.3. India Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW)
      • 6.4.4.1. Middle East Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Transcranial Magnetic Stimulation (TMS) Market Size in USD million (2021-2030)

7. Transcranial Magnetic Stimulation (TMS) Market Company and Product Profiles

  • 7.1. BrainsWay
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Nexstim
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Magstim
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Neuronetics
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Salience
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. MagVenture, Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Axilum Robotics
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Brainbox Ltd.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. EB Neuro S.p.A.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. eNeura Inc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Neurosoft
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. MAG & More GmbH
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Soterix Medical Inc.
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Magnus Medical
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. NEUROPREX INC.
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Transcranial Magnetic Stimulation (TMS) Market in Global (2021-2030)
  • Table 3: Transcranial Magnetic Stimulation (TMS) Market in Global by Type (2021-2030)
  • Table 4: Transcranial Magnetic Stimulation (TMS) Market in Global by Application (2021-2030)
  • Table 5: Transcranial Magnetic Stimulation (TMS) Market in Global by Age Group (2021-2030)
  • Table 6: Transcranial Magnetic Stimulation (TMS) Market in Global by Geography (2021-2030)
  • Table 7: Transcranial Magnetic Stimulation (TMS) Market in North America (2021-2030)
  • Table 8: Transcranial Magnetic Stimulation (TMS) Market in North America by Country (2021-2030)
  • Table 9: Transcranial Magnetic Stimulation (TMS) Market in the US (2021-2030)
  • Table 10: Transcranial Magnetic Stimulation (TMS) Market in Canada (2021-2030)
  • Table 11: Transcranial Magnetic Stimulation (TMS) Market in Mexico (2021-2030)
  • Table 12: Transcranial Magnetic Stimulation (TMS) Market in Europe (2021-2030)
  • Table 13: Transcranial Magnetic Stimulation (TMS) Market in Europe by Country (2021-2030)
  • Table 14: Transcranial Magnetic Stimulation (TMS) Market in France (2021-2030)
  • Table 15: Transcranial Magnetic Stimulation (TMS) Market in Germany (2021-2030)
  • Table 16: Transcranial Magnetic Stimulation (TMS) Market in the United Kingdom (2021-2030)
  • Table 17: Transcranial Magnetic Stimulation (TMS) Market in Italy (2021-2030)
  • Table 18: Transcranial Magnetic Stimulation (TMS) Market in Spain (2021-2030)
  • Table 19: Transcranial Magnetic Stimulation (TMS) Market in the Rest of Europe (2021-2030)
  • Table 20: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific (2021-2030)
  • Table 21: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific by Country (2021-2030)
  • Table 22: Transcranial Magnetic Stimulation (TMS) Market in China (2021-2030)
  • Table 23: Transcranial Magnetic Stimulation (TMS) Market in Japan (2021-2030)
  • Table 24: Transcranial Magnetic Stimulation (TMS) Market in India (2021-2030)
  • Table 25: Transcranial Magnetic Stimulation (TMS) Market in Australia (2021-2030)
  • Table 26: Transcranial Magnetic Stimulation (TMS) Market in South Korea (2021-2030)
  • Table 27: Transcranial Magnetic Stimulation (TMS) Market in Rest of Asia-Pacific (2021-2030)
  • Table 28: Transcranial Magnetic Stimulation (TMS) Market in the Rest of the World (2021-2030)
  • Table 29: Transcranial Magnetic Stimulation (TMS) Market in RoW by Region (2021-2030)
  • Table 30: Transcranial Magnetic Stimulation (TMS) Market in the Middle East (2021-2030)
  • Table 31: Transcranial Magnetic Stimulation (TMS) Market in Africa (2021-2030)
  • Table 32: Transcranial Magnetic Stimulation (TMS) Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Transcranial Magnetic Stimulation (TMS) Market in Global (2021-2030)
  • Figure 3: Transcranial Magnetic Stimulation (TMS) Market in Global by Type (2021-2030)
  • Figure 4: Transcranial Magnetic Stimulation (TMS) Market in Global by Application (2021-2030)
  • Figure 5: Transcranial Magnetic Stimulation (TMS) Market in Global by Age Group (2021-2030)
  • Figure 6: Transcranial Magnetic Stimulation (TMS) Market in Global by Geography (2021-2030)
  • Figure 7: Transcranial Magnetic Stimulation (TMS) Market in North America (2021-2030)
  • Figure 8: Transcranial Magnetic Stimulation (TMS) Market in North America by Country (2021-2030)
  • Figure 9: Transcranial Magnetic Stimulation (TMS) Market in the US (2021-2030)
  • Figure 10: Transcranial Magnetic Stimulation (TMS) Market in Canada (2021-2030)
  • Figure 11: Transcranial Magnetic Stimulation (TMS) Market in Mexico (2021-2030)
  • Figure 12: Transcranial Magnetic Stimulation (TMS) Market in Europe (2021-2030)
  • Figure 13: Transcranial Magnetic Stimulation (TMS) Market in Europe by Country (2021-2030)
  • Figure 14: Transcranial Magnetic Stimulation (TMS) Market in France (2021-2030)
  • Figure 15: Transcranial Magnetic Stimulation (TMS) Market in Germany (2021-2030)
  • Figure 16: Transcranial Magnetic Stimulation (TMS) Market in the United Kingdom (2021-2030)
  • Figure 17: Transcranial Magnetic Stimulation (TMS) Market in Italy (2021-2030)
  • Figure 18: Transcranial Magnetic Stimulation (TMS) Market in Spain (2021-2030)
  • Figure 19: Transcranial Magnetic Stimulation (TMS) Market in the Rest of Europe (2021-2030)
  • Figure 20: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific (2021-2030)
  • Figure 21: Transcranial Magnetic Stimulation (TMS) Market in Asia-Pacific by Country (2021-2030)
  • Figure 22: Transcranial Magnetic Stimulation (TMS) Market in China (2021-2030)
  • Figure 23: Transcranial Magnetic Stimulation (TMS) Market in Japan (2021-2030)
  • Figure 24: Transcranial Magnetic Stimulation (TMS) Market in India (2021-2030)
  • Figure 25: Transcranial Magnetic Stimulation (TMS) Market in Australia (2021-2030)
  • Figure 26: Transcranial Magnetic Stimulation (TMS) Market in South Korea (2021-2030)
  • Figure 27: Transcranial Magnetic Stimulation (TMS) Market in Rest of Asia-Pacific (2021-2030)
  • Figure 28: Transcranial Magnetic Stimulation (TMS) Market in the Rest of the World (2021-2030)
  • Figure 29: Transcranial Magnetic Stimulation (TMS) Market in RoW by Region (2021-2030)
  • Figure 30: Transcranial Magnetic Stimulation (TMS) Market in the Middle East (2021-2030)
  • Figure 31: Transcranial Magnetic Stimulation (TMS) Market in Africa (2021-2030)
  • Figure 32: Transcranial Magnetic Stimulation (TMS) Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis